Figure 3: Poor outcome of MEF2D-rearranged ALL.
From: Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia
The event-free (a,c) and overall survival (b,d) outcome of MEF2D-rearranged cases is compared with that of B-precursor ALL cases lacking known recurring chromosomal rearrangements (a,b) and key genetic subtypes (c,d) of B-ALL in the COG AALL0232 study.
